Neurotech startup Paradromics is gearing up to conduct human trials of its brain implant in the coming year, marking its entry into the competitive brain-computer interface (BCI) market where Elon Musk’s Neuralink is dominating the headlines.
What Happened: Paradromics’ upcoming trial follows a similar procedure carried out by its competitor, Neuralink, earlier this year, CNBC reported on Friday. The brain implant developed by Paradromics aims to interact with multiple neurons at once, facilitating high-speed, high-data-rate communication.
Paradromics has managed to secure $87 million in venture investment and $18 million in public funding since its establishment in 2015. The Austin-based startup anticipates the devices to ...